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Summary
 
The initiation of an immune response is critically dependent on the activation of dendritic cells
(DCs). This process is triggered by surface receptors specific for inflammatory cytokines or for
conserved patterns characteristic of infectious agents. Here we show that human DCs are acti-
vated by influenza virus infection and by double-stranded (ds)RNA. This activation results not
only in increased antigen presentation and T cell stimulatory capacity, but also in resistance to
the cytopathic effect of the virus, mediated by the production of type I interferon, and upregu-
lation of MxA. Because dsRNA stimulates both maturation and resistance, DCs can serve as al-
truistic antigen-presenting cells capable of sustaining viral antigen production while acquiring
the capacity to trigger naive T cells and drive polarized T helper cell type 1 responses.
Key words: dendritic cell maturation and activation • inﬂuenza virus • double-stranded RNA • 
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D
 
endritic cells (DCs)
 
1
 
 serve as the sentinels of the im-
mune system (1, 2). In their so-called immature state,
DCs reside in peripheral tissues, where they survey for in-
coming pathogens. Encounter with pathogens leads to DC
activation and migration to secondary lymphoid organs
where they trigger a specific T cell response. The capacity
of DCs to recognize invading microbes and become acti-
vated therefore represents the first critical event in the initi-
ation of the immune response. Because of the wide variety
of pathogens, DCs should be equipped with receptors ca-
pable of recognizing all possible offending agents and should
be able to react in such a way that they maximize the effi-
ciency of antigen presentation.
Immature DCs, similar to those found in peripheral tis-
 
sues, can be generated by culturing human monocytes with
GM-CSF and IL-4 and have been used to identify the ac-
tivation signals that induce DC maturation (3, 4). These
cells, which have a high level of endocytic activity but low
T cell stimulatory capacity, are activated to mature into
immunostimulatory DCs by the inflammatory cytokines
TNF-
 
a
 
 and IL-1, by LPS and by CD40 ligand (CD40L).
The maturation process results in upregulation of adhesion
and costimulatory molecules and downregulation of the en-
docytic activity and provides an optimal window for load-
ing exogenous antigens on MHC class II molecules (5, 6).
Influenza virus infection has been extensively used as a
model to study MHC class I–restricted antigen presentation
(7). Although the mechanisms and rules that direct loading
of viral peptides on MHC class I molecules have been ex-
tensively clarified (8–10), it is less well understood how
APCs can handle a cytopathic virus. DCs have been shown
to be much more efficient than macrophages in generating
CTL responses after infection with influenza virus (11–13)
and to be able to present on class I molecules viral antigens
taken up from infected apoptotic cells (14). In addition, it
has been suggested that infection of DCs with influenza vi-
rus can overcome the requirements for T cell help in the
stimulation of a CTL response (15), although the mechanism
has not been clarified. A relevant question to ask is how im-
mature DCs in peripheral sites can deal with infection by a
cytopathic virus. If DCs have to sustain viral antigen presen-
tation, they must be able to promptly recognize viral infec-
tion and compromise between production of viral antigens
and resistance to the cytopathic effect of the virus.
We report here that human immature DCs are activated
by influenza virus and by double-stranded (ds)RNA. In
DCs, in contrast to other cells, this stimulus leads to in-
creased protein synthesis and upregulation of MHC, adhe-
sion, and costimulatory molecules. It also results in a rapid
production of type I IFN leading to expression of MxA, a
protein that protects the DCs from the lethal effect of the
virus. By linking viral recognition to activation and resis-
tance, DCs serve as altruistic APCs capable of sustaining
 
1
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production of viral antigens while acquiring the capacity to
trigger a polarized Th1 response.
 
Materials and Methods
 
Generation and Stimulation of DCs.
 
To generate immature DCs,
peripheral blood monocytes purified by centrifugal elutriation
were cultured in RPMI-1640 supplemented with 10% FCS (Hy-
clone), 50 ng/ml GM-CSF, and 1,000 U/ml IL-4 for 6–7 d, as
previously reported (3, 4). Immature DCs were challenged with
LPS (1 
 
m
 
g/ml, from 
 
Salmonella abortus equi
 
;
 
 
 
Sigma Chemical Co.),
recombinant TNF-
 
a
 
 (50 ng/ml; R&D Systems), poly I:C (20 
 
m
 
g/
ml, Sigma Chemical Co.), and IFN-
 
a
 
 (50–500 U/ml; Roferon-A,
Roche), or infected with influenza virus strain PR8 (allantoic
fluid containing 750 HAU/ml and 4 
 
3 
 
10
 
8
 
 PFU/ml). Two neu-
tralizing sheep antisera to human type I IFN were used: Iivari
(450,000 neutralizing U/ml anti–IFN-
 
a
 
 
 
1
 
 3,000 U/ml anti–
IFN-
 
b
 
) and Kaaleppi (30,000 U/ml anti–IFN-
 
a
 
 
 
1
 
 30,000 U/ml
anti–IFN-
 
b
 
) (16).
 
Surface and Intracellular Staining.
 
DC maturation was evalu-
ated by staining the cells with antibodies to HLA class I (W6/32;
American Type Culture Collection [ATCC]), DR (L243; ATCC),
CD86 (2331; PharMingen), CD83 (HB15a; Immunotech), CD115
(3-4A4; Santa Cruz Biotechnology), and CD38 (OKT10; ATCC),
followed by FITC-labeled secondary antibodies. For intracellular
staining, the cells were fixed for 30 min with 2% paraformalde-
hyde, and permeabilized for 30 min with PBS containing 0.5%
saponin, 5% FCS, and 10 mM Hepes. The cells were stained with
rabbit anti-MxA antibody (17) and biotinylated rat anti-PR8 HA
mAb 1-10 (18), followed by appropriate secondary reagents
(Southern Biotechnology Associates, Inc.). Intracellular staining
for cytokine production was performed after stimulation of T
cells for 6 h with 10
 
2
 
7
 
 M PMA and 0.5 
 
m
 
g/ml ionomycin (Sigma
Chemical Co.). 2 h after stimulation monensin was added at 2
 
m
 
g/ml. Cells were fixed and permeabilized as above and stained
with PE-labeled anti–IL-4 and FITC-labeled anti–IFN-
 
g
 
 anti-
bodies (PharMingen).
 
Determination of Cell Viability.
 
Viability of the cells after PR8
infection was evaluated by staining cells with FITC-labeled An-
nexin V (PharMingen) and propidium iodide. The samples were
analyzed on a FACScalibur
 
®
 
 using Cell Quest software (Becton
Dickinson).
 
Immunoblotting.
 
Identical numbers of unstimulated DCs or
DCs treated with different stimuli for 5 or 13 h were lysed in lysis
buffer (100 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton
X-100, 5 mM EDTA, 1 mM PMSF, 10 
 
m
 
g/ml aprotinin, and 10
 
m
 
g/ml leupeptin). Lysates were solved by 8% SDS-PAGE under
reducing conditions, and transferred to nitrocellulose membranes
(Amersham). After blocking with PBS/0.1% Tween/5% nonfat
dry milk, the membranes were incubated with the rabbit anti-
MxA antiserum (17), followed by horseradish peroxidase–conju-
gated goat anti-rabbit IgG (Southern Biotechnology Associates).
Proteins were visualized by chemiluminescence using the ECL
detection reagents (Amersham).
 
Cytokine Determination.
 
IL-12 p40 and p75 levels were mea-
sured by ELISA as previously described (19). Type I IFN was
measured evaluating inhibition of Daudi cell proliferation (20)
with reference to a standard IFN-
 
a
 
 curve. The sensitivity of the
assay was 0.2 U/ml.
 
Class I Synthetic Rate and Stability.
 
5 h after stimulation or in-
fection, DCs were labeled with 
 
35
 
S[methionine]/cysteine (Amer-
sham) for 1 h. Cells were chased for one additional hour or
longer; identical number of cells were lysed and HLA class I mol-
ecules were immunoprecipitated using the W6/32 mAb (ATCC)
followed by protein G–Sepharose (Pharmacia Biotech). The pre-
cipitates were resolved by SDS-PAGE and the radioactivity of
specific bands was quantified by PhosphorImager (Molecular Dy-
namics). DCs do not divide during the assay. Total protein syn-
thesis was estimated by counting the radioactivity incorporated
by a fixed number of cells.
 
T Lymphocyte Stimulation.
 
Immature HLA-A2
 
1
 
 DCs either
were pulsed for 1 h with 1 
 
m
 
g/ml Influenza Matrix 58-66 pep-
tide or were infected with PR8. After 5 or 24 h, a graded num-
ber of cells were tested for their capacity to trigger proliferation
of a specific T cell clone (21). In a different set of experiments,
immature DCs were left untreated or were pretreated for 40 h
with poly I:C, LPS, TNF-
 
a
 
, and IFN-
 
a
 
, or were infected with
PR8. After irradiation (1,500 rad), a graded number of cells were
cultured with allogeneic T cells and the proliferative response was
measured on day 5 by [
 
3
 
H]thymidine incorporation (Amersham).
Naive T cells were either derived from cord blood or from adult
donors lymphocytes, negatively depleted of CD8, CD14, CD20,
CD56, HLA class II, CD45 RO
 
1
 
 cells. The resulting population
was 99% composed of CD4
 
1
 
CD45RA
 
1
 
 cells. Cells were stimu-
lated with differently matured DCs, at a responder/stimulator ra-
tio of 10:1, in the absence or presence of neutralizing anti–IL-12
antibodies (19).
 
Results
 
Susceptibility of DCs to Influenza Virus Infection Correlates
with Expression of MxA.
 
Immature DCs can be generated
by culturing peripheral blood monocytes with GM-CSF
and IL-4 (3, 4). These cells are competent in antigen capture
and mature when stimulated by LPS, TNF-
 
a
 
, or CD40L,
losing their antigen-capturing capacity and acquiring T cell
stimulatory capacity. Immature and mature DCs, obtained
after LPS or TNF-
 
a
 
 stimulation, were incubated with dif-
ferent doses of influenza virus strain PR8, and the propor-
tion of infected cells was measured after 14 h by staining
with a specific mAb. As shown in Fig. 1, there was a dose-
dependent increase in the percentage of cells expressing vi-
ral proteins as well as in the level of viral proteins expressed
by individual cells. Immature and TNF-
 
a
 
–matured DCs
were highly susceptible to influenza virus infection: at high
multiplicity of infection (MOI), all cells expressed high lev-
els of viral protein, whereas at low multiplicity viral pro-
teins were expressed in a bimodal distribution. In contrast,
LPS-matured DCs were more, and in some experiments
completely, resistant to infection; at high MOI they
showed a bimodal protein expression, whereas at low mul-
tiplicity only a small proportion of cells was infected, ex-
pressing low levels of viral proteins. Finally, DCs pretreated
for 40 h with IFN-
 
a
 
 were almost completely resistant to
infection. The different susceptibility of DCs to influenza
infection could not be explained by their different levels of
endocytic activity. TNF-
 
a
 
–matured DCs, which had com-
pletely lost endocytic activity, were equally, if not more,
susceptible to infection than immature DCs. Conversely,
IFN-
 
a
 
–treated DCs, which were as endocytic as immature
DCs (data not shown), were completely resistant.
In search for a mechanism that might modulate the sus-
ceptibility of DCs to influenza virus infection, we investi- 
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gated the expression of MxA, a protein induced by type I
IFN, that is known to mediate resistance to several viruses
including influenza (22, 23). MxA was initially identified
by two-dimensional gel analysis as a protein abundantly
represented in LPS-matured but not immature DCs (Saka-
kibara, Y., unpublished data).
Fig. 2 shows the level of MxA expression in relation to
the level of production of viral HA (A–G) and to the via-
bility of the infected cells (H–P). Immature DCs did not
express MxA, but became MxA
 
1
 
 after infection with PR8,
explaining their capacity to resist the cytopathic effect of
the virus. At low MOI (1:1), immature DCs could be effi-
ciently infected (61%) with no increase in cell death over
the background, whereas at higher MOI they were in-
fected more efficiently and produced higher protein levels,
but showed progressively lower viability. In contrast, LPS-
matured DCs, which already expressed MxA, required
 
z
 
10-fold higher doses of virus to produce comparable
amounts of proteins, but were far more resistant to the cy-
topathic effect even at an MOI of 100:1. Taken together,
these results suggest that susceptibility to influenza virus in-
fection is modulated in DCs by the expression of MxA,
which is induced by LPS stimulation as well as by infection
with influenza virus.
 
MxA Is Induced by Autocrine Production of Type I IFN.
 
The time course of MxA protein expression was analyzed
in DCs challenged with different stimuli, either by immu-
nofluorescence on fixed and permeabilized cells or by im-
munoblotting (Fig. 3, A and B). MxA was induced with
comparable fast kinetics by IFN-
 
a
 
, LPS, and PR8 infec-
tion, as well as by poly I:C, a synthetic source of dsRNA.
In contrast, TNF-
 
a
 
 failed to induce MxA expression, and
CD40L induced it only to a low extent and with a slower
kinetics.
The capacity of different stimuli to induce MxA corre-
lated with their capacity to induce production of type I
IFN by DCs (Fig. 3 C). Both poly I:C and LPS led to a
rapid production of type I IFN that reached a plateau at 4 h,
whereas PR8 infection induced an equally rapid, but more
sustained and consistently higher production. In contrast,
TNF-
 
a
 
 and CD40L stimulation did not induce production
of detectable levels of IFN.
These results demonstrate that DCs can produce type I
IFN in response to specific stimuli, which in turn leads to
upregulation of MxA gene expression via an autocrine
loop. To address this possibility, we evaluated the capacity
of neutralizing antibodies to type I IFNs to inhibit MxA
expression (Fig. 3 D). The antisera we used completely ab-
rogated MxA upregulation at 5 h induced by recombinant
IFN-
 
a
 
, PR8 infection, and CD40L. However, they also
inhibited significantly, although not completely (at least
50%), MxA induction after LPS or poly I:C stimulation.
Although these results do not rule out the possibility of an
IFN-
 
a
 
–independent MxA upregulation, they suggest that
autocrine production of type I IFN by DCs represents a
major mechanism to ensure the rapid build-up of a resis-
tance state to the infecting virus.
Figure 1. Susceptibility to influenza virus infection of DC populations.
(A and B) Percentage of DCs expressing viral proteins at high levels (A)
or high plus low levels (B) 14 h after infection with different doses of
PR8; immature DCs (j), TNF-a–matured DCs (n), LPS-matured DCs
(e), IFN-a–treated DCs (s). The proportion of DCs expressing viral
proteins and the level of expression were comparable when measured at
40 h (data not shown). (C and D) Level of expression of viral protein in
DCs infected with PR8 at 5 HAU/ml (C) or 0.1 HAU/ml (D). The DCs
were either untreated (1) or pretreated for 30 h with TNF-a (2), LPS (3),
or IFN-a (4). Second antibody control (0).
Figure 2. LPS-matured DCs
express MxA protein and are
more resistant than immature
DCs to the cytopathic effect of
influenza virus at high MOI. Im-
mature DCs were left untreated
(A and H) or were infected with
PR8 at 1 HAU/ml (B and I), 10
HAU/ml (C and L) or 30 HAU/
ml (D and M). Mature DCs (40 h
after LPS) were left untreated
(E and N) or were infected with
PR8 at 10 HAU/ml (F and O)
or 100 HAU/ml (G and P). After
24 h the cells were tested for the
expression of MxA and influenza
HA proteins (A–G). Viable, early
and late apoptotic cells were
evaluated in the same samples
by staining with FITC-labeled
Annexin V and propidium iodide
(H–P). 
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dsRNA and PR8 Upregulate Protein Synthesis in Immature
and IFN-
 
a
 
–treated DCs.
 
dsRNA has been shown to trig-
ger PKR, an IFN-
 
a
 
–induced kinase that inactivates eIF2,
thereby reducing protein synthesis (24). This mechanism
may be important to ensure reduction of viral replication
and elimination of infected cells. However, PKR has also
been shown to activate NF-
 
k
 
B (25) and transcription.
PKR was expressed constitutively in DCs and its level was
not further increased upon IFN-
 
a
 
 treatment (data not
 
shown). We thus compared the effect of poly I:C and PR8
on protein synthesis in DCs and Hela cells before and after
treatment with IFN-
 
a
 
 (Fig. 4). As expected, PR8 infection
and poly I:C induced a marked decrease in the rate of total
and MHC class I protein synthesis in IFN-
 
a
 
–pretreated,
but not in untreated, Hela cells. In contrast, in DCs the
same treatments resulted in a strong boost of total, and par-
ticularly MHC class I, protein synthesis, irrespective of
whether or not the cells had been pretreated with IFN-
 
a
 
.
These results demonstrate that, as compared with other cell
types, DCs have a unique capacity to respond to dsRNA, a
property that may be important to allow efficient presenta-
tion of viral antigens.
 
Influenza Virus Infection Promotes and Sustains Generation of
Peptide–MHC Class I Complexes.
 
We next investigated
whether stimulation of DCs by infectious virus might opti-
mize loading of class I molecules with antigenic peptides.
In PR8-infected DCs there was a strong upregulation of
HLA class I synthesis (5–10-fold in four experiments) (Fig.
5 A). Furthermore, the class I molecules synthesized during
the initial stages of infection displayed a two- to threefold
longer half-life than those synthesized in immature or in
LPS-treated DCs (Fig. 5 B). This increased stability may be
related to the abundant supply of high affinity peptides de-
rived from degradation of viral proteins, since it was not
noticed in DCs stimulated with LPS.
PR8-infected immature DCs rapidly acquired a high ca-
pacity to trigger an HLA-A2–restricted T cell clone specific
for the influenza matrix peptide M58-66. Furthermore,
the stimulatory capacity increased with time after infection
(Fig. 5 C). In contrast, although immediately stimulatory,
immature DCs pulsed with a high dose of M58-66 peptide
lost the capacity to stimulate specific T cells by 20 h of cul-
ture, a finding consistent with the short half-life of MHC
class I–peptide complexes. In addition, IFN-
 
a
 
–pretreated
Figure 3. MxA expression is rapidly induced in DCs by LPS, poly I:C
and viral infection. Time course of MxA upregulation as detected by in-
tracellular staining (A) or immunoblotting (B). (C) Time course of type I
IFN production in culture supernatant. DCs were stimulated with the
following: 50 U/ml IFN-a (s, panel A only), LPS (n), 20 mg/ml poly I:C
(j), 1 HAU PR8 (d), TNF-a (,), and CD40L (e). (D) MxA induc-
tion after 5 h of stimulation in the absence (black bar) or in the presence
of two neutralizing sheep antisera to human type I IFN: Iivari, hatched
bars, and Kaaleppi, empty bars.
Figure 4. dsRNA and PR8 infection in-
duce upregulation of total protein and HLA
class I synthesis in untreated as well as in
IFN-a–pretreated DCs. Total protein syn-
thesis (hatched bars) and HLA class I synthe-
sis (black bars) were measured in DCs (A and
C) or Hela cells (B and D) 5 h after stimula-
tion with 20 mg/ml poly I:C, 5 HAU PR8,
or medium alone. The cells were either un-
treated (A and B) or pretreated for 24 h with
500 U/ml IFN-a (C and D). 
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DCs, which were highly resistant to viral infection, did not
stimulate the virus-specific T cell clone even at late time
points.
Taken together, these results indicate that in PR8-
infected DCs the increased synthesis and loading of MHC
class I molecules results in a rapid and continuous produc-
tion of large numbers of complexes containing viral pep-
tides. These events allow presentation to T cells to be sus-
tained over a long period of time.
 
Influenza Virus Infection and dsRNA Trigger DC Maturation
and Prime for a Th1 Response.
 
We compared dsRNA and
influenza virus infection to known stimuli for their capacity
to induce DC maturation. As a readout we analyzed the
expression of costimulatory molecules and the production
of Th1 polarizing cytokines (i.e., IL-12 [26]), and evaluated
the capacity of DCs to stimulate and polarize allogeneic na-
ive T cells. As shown in Table I, poly I:C and PR8 in-
duced a marked upregulation of MHC class I and class II,
CD80, CD86, CD83, and CD38, and downregulation of
CD115, a phenotype characteristic of mature DCs (19, 27).
In addition, poly I:C and PR8 induced the production of
low but significant levels of IL-12 p75 (1–2 ng/ml), al-
though the amount detected was always lower (at least 10–
50-fold) than that induced via CD40L (19). Although
TNF-
 
a
 
 stimulation never led to production of bioactive
IL-12, low levels of IL-12 p75 (0.1–0.2 ng/ml) were de-
tectable after LPS stimulation. On the other hand, IFN-
 
a
 
tested over a broad range of concentrations (10–500 U/ml)
did not induce DC maturation but only upregulation of
HLA class I and a modest shift in the expression of CD38
and CD86 with no significant increase in CD83, HLA class
II, or other costimulatory and adhesion molecules.
Consistent with the effect on DC maturation and cytokine
production, poly I:C and PR8 increased 
 
z
 
30-fold the capac-
ity of DCs to stimulate a proliferative response by allogeneic
CD45RA
 
1
 
CD4
 
1
 
 T cells, whereas IFN-
 
a
 
 treatment did not
show a significant effect. Poly I:C-matured DCs were as effi-
cient as DCs induced to mature by TNF-
 
a
 
 or LPS (Fig. 6).
Although the ability to trigger T cell proliferation was com-
parable, the capacity to polarize T cells was remarkably differ-
ent, depending on the nature of the maturative stimulus
applied. Alloreactive T cells expanded by TNF-
 
a
 
–matured
DCs were poorly polarized (only 32% of cells producing ei-
ther IFN-
 
g
 
 or IL-4) and consisted of both Th1 and Th2 (Fig.
7 A). In contrast, T cells expanded by poly I:C-matured DCs
were highly polarized (70–90%, in different experiments)
with most of the cells producing high amounts of IFN-g,
consistent with a dominant Th1 phenotype (Fig. 7 B). Addi-
tion of neutralizing antibodies to IL-12 prevented Th1 polar-
Figure 5. Increase in MHC class I biosynthesis and stability induced by
PR8 infection allows efficient presentation of viral antigen to cytotoxic T
cells. (A) Synthetic rate and stability of HLA class I molecules in immature
DCs and in DCs that were stimulated for 5 h with 5 HAU/ml PR8 or
LPS. Labeled class I molecules were precipitated after 1 h of chase (time
0) or after 12 or 24 h. (B) Half-life of labeled HLA class I molecules quan-
titated by PhosphorImager in immature DCs (s), LPS-treated DC (d),
or PR8-infected DC (m). (C) Proliferative response of an HLA-A2–
restricted M58-66–specific T cell clone cultured with graded numbers of
HLA-A21 DCs. DCs were either pulsed with 1 mM M58-66 peptide
(circles) or infected with 5 HAU/ml PR8 with (triangles) or without
(squares) IFN-a (500 U/ml) pretreatment. DCs were tested 5 h (open
symbols) or 24 h after pulsing (filled symbols).
Table I. DC Maturation and IL-12 p75 Production Are Induced by dsRNA and Influenza Virus Infection
Stimuli* Class I HLA-DR CD86 CD83 CD38 CD115 IL-12 p75§
Untreated 370 575 11 3 17 71 10
PR8‡ 1,576 1,441 261 133 134 11 527
Poly I:C 729 866 264 112 108 5 1,218
LPS 973 1,087 200 157 121 8 185
TNF-a 634 1,012 67 69 15 4 11
IFN-a 525 519 32 4 37 34 16
*Immature DCs were challenged with different stimuli for 40 h and analyzed for expression of surface markers. PR8 was used at 5 HAU/ml, poly I:C
at 20 mg/ml, LPS at 1 mg/ml, TNF-a at 50 ng/ml, and IFN-a at 50 U/ml. Data from one out of six experiments with comparable results are shown
as mean fluorescent intensity.
‡PR8 inactivated at 56°C did not show any detectable effect.
§IL-12 p75 is expressed in pg/ml.826 DC Activation and Protection Induced by Influenza Virus
ization, skewing the cultures towards a Th2 phenotype (Fig.
7 C). In some experiments, the inhibition of Th1 develop-
ment required the simultaneous neutralization of type I IFN
and IL-12 (data not shown). Taken together, these results in-
dicate that dsRNA and influenza virus infection can induce
DC maturation, and confer the capacity to prime a Th1 re-
sponse through the production of IL-12 and type I IFN.
Discussion
Protection and Maturation of DCs Induced by the Viral Pat-
tern dsRNA. We have shown that dsRNA induces two
functionally distinct responses in DC: (i) protection from
the viral cytopathic effect, and (ii) maturation, leading to
increased capacity to prime and polarize T cells. In the
course of viral infection, the simultaneous induction of
protection and maturation optimizes loading of viral anti-
gens on MHC class I molecules.
dsRNA is a classical inducer of type I IFN (28–30),
which plays a critical role in antiviral responses (31, 32).
DCs represent a strategic source of type I IFN and we have
shown that it is produced not only in response to dsRNA
or virus infection (33), but also in response to LPS stimula-
tion. However, IFN is not produced in response to other
stimuli such as TNF-a, and only in minute amounts in re-
sponse to CD40L. Type I IFN produced by DCs results in
rapid induction of MxA, a cytoplasmic protein that has
been shown to protect cells from the cytopathic effect of
some viruses (22, 23, 34). Neutralizing antibodies to type I
IFN completely inhibited MxA induction by recombinant
exogenous IFN-a, influenza virus infection, and CD40L,
but only partially inhibited MxA upregulation by poly I:C
or LPS, suggesting a possible direct activation of MxA ex-
pression independent from type I IFN (35).
dsRNA and viral infection also induced a rapid matura-
tion of DCs with upregulation of MHC, adhesion, and co-
stimulatory molecules. These phenotypic changes were to a
large extent comparable to those induced by other matura-
tion stimuli such as LPS, TNF-a, or CD40L, although a
different pattern in cytokine production was observed. These
results may well account for the increased capacity of influ-
enza virus–infected DCs to stimulate CTL responses (15).
Although a minor shift in CD38 and CD86 was reproduc-
ibly observed, IFN-a per se was unable to support a com-
plete DC maturation. The maturation effect of type I IFN
reported in other studies was observed in a different culture
system and was dependent on the simultaneous presence of
TNF-a, which by itself is a DC maturation factor (36).
The signal transduction pathway triggered by dsRNA
has been studied in detail. It has been shown that dsRNA
activates PKR, a serine-threonine kinase that phosphory-
lates and inactivates eIF2, thereby shutting off protein syn-
thesis (24). PKR can also activate NF-kB (25) and conse-
quently may induce transcription of genes involved in DC
maturation. The fact that PKR-deficient mice can still re-
spond to dsRNA suggests that there may be additional
pathways of signal transduction that may be operative in
DCs (37). The relative role and function of the pathways
activated by dsRNA may vary in different cells. Our exper-
iments show that the response to dsRNA in DCs and Hela
cells is considerably different. In Hela cells dsRNA induces
a downregulation of protein synthesis, whereas in imma-
ture DCs dsRNA actually upregulates total protein synthe-
sis, while fully inducing the maturation process.
It has been suggested that recognition of conserved mo-
lecular patterns characteristic of pathogens is a property of
the innate immune system, which is instrumental to initiat-
ing and regulating the adaptive immune response (38). Our
results clearly indicates that dsRNA behaves as one of such
molecular patterns. dsRNA can directly signal to the APCs
Figure 6. PR8 infection and poly I:C increase the T cell stimulatory ca-
pacity of DCs. Proliferative response of cord blood naive T cells stimulated
with graded numbers of irradiated allogeneic DCs. DCs were untreated
(d) or pretreated for 24 h with 50 U/ml IFN-a (3), LPS (e), TNF-a
(n), or 20 mg/ml poly I:C (h), or infected with 3 HAU/ml PR8 (s).
Figure 7. Poly I:C primes for
a Th1 response. IFN-g and IL-4
production by polyclonal T cell
lines generated by stimulating
purified CD45RA1CD41 T
cells with allogeneic DCs. A,
TNF-a–matured DCs; B, poly
I:C-matured DCs; C, poly I:C-
matured DCs in the presence of
neutralizing antibodies to IL-12.
A strong Th1 response was also
obtained with LPS-matured DCs
(data not shown). In some ex-
periments both anti–IL-12 and
anti–IFN-a antibodies were re-
quired to inhibit Th1 develop-
ment. Anti–IL-12 antibodies did
not affect polarization induced
by TNF-a–matured or imma-
ture DCs.827 Cella et al.
the presence of an infectious agents and, by activating the
DCs, can lead to activation of lymphocytes bearing clonally
specific antigen receptors, thus triggering an adaptive im-
mune response. The relevance of this recognition system is
also underlined by the fact that many viruses specifically
target the dsRNA-binding protein PKR to escape immune
recognition (39–41).
Sustained Synthesis of Viral Antigens and Class I Molecules
Maximizes Antigen Presentation. We have shown that effi-
cient presentation influenza virus is the result of a delicate
compromise. On one hand, immature DCs are highly sus-
ceptible to infection and thus produce large amounts of vi-
ral proteins. On the other hand, they can rapidly build up
resistance to the virus, thus limiting its cytopathic effect.
The importance of synchronizing these two functions is il-
lustrated by the fact that IFN-a–pretreated DCs, which are
resistant to influenza infection, are extremely inefficient at
presenting viral antigens.
The dramatic upregulation of class I synthesis (up to 10-
fold) induced by viral infection is an important mechanism
that ensures effective presentation of viral antigens. MHC
class I synthesis is sustained after induction of maturation,
allowing continuous accumulation of peptide–MHC com-
plexes and thus compensating for the relatively short half-
life of class I molecules (10–20 h). The importance of the
sustained antigen loading is exemplified by the fact that al-
though the capacity to stimulate class I–restricted, virus-
specific T cells is rapidly lost in peptide-pulsed DCs, it ac-
tually increases with time in virus-infected DCs. This fact
should be taken into account when considering the use of
DCs as vaccines to induce class I–restricted responses.
We have previously shown that in maturing DCs the
synthesis of class II molecules is transiently upregulated and
subsequently stopped, while stable peptide class II com-
plexes are retained with extremely long half-lives (.100 h)
(5). In contrast, in DCs MHC class I molecules have a short
half-life that is not significantly affected by the maturation
process. The different regulation of class I and class II bio-
synthesis and stability in DCs makes good sense. Class II
molecules present antigens that are transiently encountered
in the surrounding environment, so it is important for a
DC to be able to load antigenic peptides over a short pe-
riod of time and retain the antigen as a stable complex. In-
stead, the short half-life of class I molecules is instrumental
to allow a continuous monitoring of early and late viral an-
tigens, as long as the cell remains infected.
Flexibility in Cytokine Production Determines the T Cell Po-
larizing Capacity of DCs. Although DCs induced to ma-
ture by different stimuli share several common features,
such as the increase in MHC, costimulatory molecules, and
T cell stimulatory capacity (3, 19), consistent differences are
observed in the pattern of cytokines produced in response
to the different stimuli. These in turn determine both the
extent and the type of T cell polarization, suggesting that
mature DCs can exist in different functional states. TNF-
a–matured DCs, which produce neither IL-12 nor type I
IFN, were highly stimulatory, but induced only a low per-
centage of fully polarized cells. In contrast, dsRNA- or
LPS-matured DCs, which produced both type I IFN and
IL-12 (although in different proportions) elicited strong
Th1 polarization, with 70–90% of T cells producing high
levels of IFN-g. The Th1 polarizing effect was inhibited in
most cases by neutralization of IL-12, although in some
cases neutralization of type I IFN was also required, as pre-
viously reported for monocytes (30). These results indicate
a flexibility of DCs in the use of Th1 polarizing cytokines
and suggest that a multiplicity of responses can be gener-
ated by distinct environmental signals. In addition, it is pos-
sible that the relative production of IL-12 and type I IFN
may play a more subtle role in modulating T cell polariza-
tion. Although both IL-12 (26) and type I IFN in humans
(42) are known to drive Th1 polarization, it is possible that
they may play distinct roles by differentially regulating IL-4
and IL-13 production by T cells (43).
Our results also imply that the nature of the signal induc-
ing DC maturation may determine the capacity of the DCs
to generate polarized immune responses. On one hand,
stimuli from viral or bacterial patterns (dsRNA or LPS) or
T cell help, through CD40–CD40L interaction, generate
DCs capable of priming strong Th1 responses. On the
other hand, an endogenous inflammatory stimulus, such as
TNF-a, generates DCs capable of inducing a more bal-
anced response, comprising both Th1 and Th2 cells. The
fact that the same DCs can mature to different functional
states capable of stimulating polarized Th1 or Th2 re-
sponses makes good sense, since it allows the APCs to ini-
tiate a response that is appropriate for the signal received and
has practical implications for the therapeutic use of DCs.
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